SPY411.45-1.41 -0.34%
DIA337.53+0.74 0.22%
IXIC13,857.84-138.26 -0.99%

Codiak BioSciences: On Track to Report Biomarker, Safety and Clinical Anti-Tumor Efficacy Results in Cancer Patients >CDAK

Codiak BioSciences: On Track to Report Biomarker, Safety and Clinical Anti-Tumor Efficacy Results in Cancer Patients >CDAK

· 03/17/2021 07:37

Please log in to view news